TOX is a critical regulator of tumour-specific T cell differentiation

被引:726
|
作者
Scott, Andrew C. [1 ,2 ]
Dundar, Friederike [3 ,4 ]
Zumbo, Paul [3 ,4 ]
Chandran, Smita S. [5 ,6 ]
Klebanoff, Christopher A. [5 ,6 ,7 ,8 ]
Shakiba, Mojdeh [1 ,3 ]
Trivedi, Prerak [1 ]
Menocal, Laura [1 ,2 ]
Appleby, Heather [1 ]
Camara, Steven [1 ]
Zamarin, Dmitriy [5 ,7 ]
Walther, Tyler [7 ]
Snyder, Alexandra [7 ]
Femia, Matthew R. [5 ,6 ]
Comen, Elizabeth A. [7 ,8 ]
Wen, Hannah Y. [9 ]
Hellmann, Matthew D. [5 ,7 ,8 ]
Anandasabapathy, Niroshana [2 ,10 ]
Liu, Yong [10 ]
Altorki, Nasser K. [11 ]
Lauer, Peter [12 ]
Levy, Olivier [1 ]
Glickman, Michael S. [1 ,2 ]
Kaye, Jonathan [13 ]
Betel, Doron [4 ,14 ,15 ]
Philip, Mary [1 ,16 ]
Schietinger, Andrea [1 ,2 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA
[3] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA
[4] Weill Cornell Med, Appl Bioinformat Core, New York, NY USA
[5] Parker Inst Canc Immunotherapy, New York, NY 10017 USA
[6] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med Coll, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
[10] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA
[11] New York Presbyterian Hosp, Dept Cardiothorac Surg, Weill Cornell Med, New York, NY USA
[12] Aduro Biotech Inc, Berkeley, CA USA
[13] Cedars Sinai Med Ctr, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA
[14] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[15] Weill Cornell Med, Inst Computat Biomed, New York, NY USA
[16] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN USA
关键词
EXHAUSTION; PROMOTES; DYSFUNCTION; ANTIGEN; AUTOIMMUNITY; EXPRESSION; GENERATION; PROTEINS; EFFECTOR; PROGRAM;
D O I
10.1038/s41586-019-1324-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the functional effector or memory T cell states(1-6). Here we identify the nuclear factor TOX as a crucial regulator of the differentiation of tumour-specific T (TST) cells. We show that TOX is highly expressed in dysfunctional TST cells from tumours and in exhausted T cells during chronic viral infection. Expression of TOX is driven by chronic T cell receptor stimulation and NFAT activation. Ectopic expression of TOX in effector T cells in vitro induced a transcriptional program associated with T cell exhaustion. Conversely, deletion of Tox in TST cells in tumours abrogated the exhaustion program: Tox-deleted TST cells did not upregulate genes for inhibitory receptors (such as Pdcd1, Entpd1, Havcr2, Cd244 and Tigit), the chromatin of which remained largely inaccessible, and retained high expression of transcription factors such as TCF-1. Despite their normal, 'non-exhausted' immunophenotype, Tox-deleted TST cells remained dysfunctional, which suggests that the regulation of expression of inhibitory receptors is uncoupled from the loss of effector function. Notably, although Tox-deleted CD8 T cells differentiated normally to effector and memory states in response to acute infection, Tox-deleted TST cells failed to persist in tumours. We hypothesize that the TOX-induced exhaustion program serves to prevent the overstimulation of T cells and activation-induced cell death in settings of chronic antigen stimulation such as cancer.
引用
收藏
页码:270 / +
页数:27
相关论文
共 50 条
  • [21] T cell differentiation in Sjogren syndrome is regulated by TOX
    Phillips, Robert
    NATURE REVIEWS RHEUMATOLOGY, 2022, 18 (08) : 432 - 432
  • [22] INDUCTION OF TOLERANCE TO TUMOUR-SPECIFIC ANTIGEN
    KOLDOVSKY, P
    SVOBODA, J
    TRANSPLANTATION BULLETIN, 1962, 29 (02): : 507 - 507
  • [23] INDUCTION OF TOLERANCE TO TUMOUR-SPECIFIC ANTIGEN
    KOLDOVSKY, P
    SVOBODA, J
    FOLIA BIOLOGICA, 1961, 7 (06) : 424 - &
  • [24] Radiotherapy supports tumour-specific immunity
    Van den Broek, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S281 - S281
  • [25] Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control
    Steinbach, Philine
    Pastille, Eva
    Kaumanns, Lara
    Adamczyk, Alexandra
    Sutter, Kathrin
    Hansen, Wiebke
    Dittmer, Ulf
    Buer, Jan
    Westendorf, Astrid M.
    Knuschke, Torben
    PLOS PATHOGENS, 2024, 20 (01)
  • [26] Tumour-specific radiosensitisation by ATR inhibitors
    Brunner, T.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S90 - S90
  • [27] \ Oncolytic measles vectors for tumour-specific vaccination
    Kubon, K.
    Czink, E.
    Osen, W.
    Eichmueller, S.
    Jaeger, D.
    von Kalle, C.
    Ungerechts, G.
    Engeland, C. E.
    HUMAN GENE THERAPY, 2017, 28 (12) : A31 - A31
  • [28] T cell differentiation in Sjögren syndrome is regulated by TOX
    Robert Phillips
    Nature Reviews Rheumatology, 2022, 18 : 432 - 432
  • [29] SEMAPHORIN 3A INCREASES TUMOUR-SPECIFIC T-CELL MEDIATED CYTOTOXICITY IN AN AUTOLOGOUS AND ALLOGENEIC SETTING
    Figueiredo, Constanca
    Schlahsa, Laura
    Zhang, Haijiao
    Goudeva, Lilia
    Eiz-Vesper, Britta
    Immenschuh, Stephan
    Blasczyk, Rainer
    TISSUE ANTIGENS, 2014, 84 (01): : 10 - 11
  • [30] Anticancer drugs: Tumour-specific angiogenesis inhibition
    Crunkhorn S.
    Nature Reviews Drug Discovery, 2016, 15 (5) : 310 - 310